title: A clozapine-like effect of cyproheptadine on progressive ratio schedule performance.
abstract: The atypical antipsychotic drug clozapine has multiple pharmacological actions, some of which, including 5-hydroxytryptamine (5-HT₂) and histamine (H₁) receptor antagonist effects, are shared by the non-selective 5-HT receptor antagonist cyproheptadine. Atypical antipsychotics have a characteristic profile of action on operant behaviour maintained by progressive ratio schedules, as revealed by Killeen's (1994) mathematical model of schedule controlled behaviour. These drugs increase the values of a parameter that expresses the 'incentive value' of the reinforcer (a) and a parameter that is inversely related to the 'motor capacity' of the organism (δ). This experiment examined the effects of acute treatment with cyproheptadine and clozapine on performance on a progressive ratio schedule of food reinforcement in rats; the effects of a conventional antipsychotic, haloperidol, and two drugs with food intake-enhancing effects, chlordiazepoxide and Δ⁹-tetrahydrocannabinol (THC), were also examined. Cyproheptadine (1, 5 mg kg⁻¹) and clozapine (3.75, 7.5 mg kg⁻¹) increased a and δ. Haloperidol (0.05, 0.1 mg kg⁻¹) reduced a and increased δ. Chlordiazepoxide (3, 10 mg kg⁻¹) increased a but reduced δ. THC (1, 3 mg kg⁻¹) had no effect. Interpretation based on Killeen's (1994) model suggests that cyproheptadine and clozapine enhanced the incentive value of the reinforcer and impaired motor performance. Motor impairment may be due to sedation (possibly reflecting H₁ receptor blockade). Enhancement of incentive value may reflect simultaneous blockade of H₁ and 5-HT₂ receptors, which has been proposed as the mechanism underlying the food intake-enhancing effect of cyproheptadine. In agreement with previous findings, haloperidol impaired motor performance and reduced the incentive value of the reinforcer. Chlordiazepoxide's effect on a is consistent with its food intake-enhancing effect.
authors: Psychopharmacology Section, Division of Psychiatry, University of Nottingham, Nottingham, UK.
authors: C M
authors: CM
authors: Olarte-Sánchez
authors: L
authors: L
authors: Valencia Torres
authors: S
authors: S
authors: Body
authors: H J
authors: HJ
authors: Cassaday
authors: C M
authors: CM
authors: Bradshaw
authors: E
authors: E
authors: Szabadi
authors: A J
authors: AJ
authors: Goudie
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D002707:Chlordiazepoxide / Q000494:pharmacology; D003024:Clozapine / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects; D003533:Cyproheptadine / Q000494:pharmacology*; D013759:Dronabinol / Q000494:pharmacology; D004435:Eating / Q000187:drug effects; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D009042:Motivation / Q000187:drug effects; D058573:Performance-Enhancing Substances / Q000494:pharmacology*; D011597:Psychomotor Performance / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D012055:Reinforcement Schedule; D012054:Reinforcement, Psychology
chemical_list: D014150:Antipsychotic Agents; D058573:Performance-Enhancing Substances; D003533:Cyproheptadine; D002707:Chlordiazepoxide; D013759:Dronabinol; D003024:Clozapine; D006220:Haloperidol